MARSH & MCLENNAN COS (MMC) Forecast, Price Target & Analyst Ratings
NYSE:MMC • US5717481023
182.7 USD
-2.93 (-1.58%)
At close: Jan 13, 2026
182.7 USD
0 (0%)
After Hours: 1/13/2026, 8:04:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MARSH & MCLENNAN COS (MMC).
Forecast Snapshot
Consensus Price Target
$214.06
+ 17.16% Upside
Next Earnings Forecast
Release DateJan 29, 2026
PeriodQ1 / 2026
EPS Estimate$3.26
Revenue Estimate7.497B
ChartMill Buy Consensus
67.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$214.06
Upside
+ 17.16%
From current price of $182.70 to mean target of $214.06, Based on 28 analyst forecasts
Low
$175.74
Median
$209.61
High
$270.90
Price Target Revisions
1 Month
-0.87%
3 Months
-9.28%
Price Target Summary
28 analysts have analysed MMC and the average price target is 214.06 USD. This implies a price increase of 17.16% is expected in the next year compared to the current price of 182.7.
The average price target has been revised downward by 9.28% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
67.86%
MMC was analyzed by 28 analysts. The buy percentage consensus is at 68. So analysts seem to be have mildly positive about MMC.
In the previous month the buy percentage consensus was at a similar level.
MMC was analyzed by 28 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-14 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2026-01-13 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-08 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-01-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-06 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-12-16 | Mizuho | Initiate | Outperform |
| 2025-12-04 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-11-20 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2025-11-03 | TD Cowen | Maintains | Hold -> Hold |
| 2025-11-03 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2025-10-20 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2025-10-17 | Keefe, Bruyette & Woods | Upgrade | Underperform -> Market Perform |
| 2025-10-17 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-17 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-09 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-10-08 | UBS | Maintains | Buy -> Buy |
| 2025-10-08 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-08 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-07 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-09-16 | Wolfe Research | Initiate | Peer Perform |
| 2025-08-18 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-13 | Citigroup | Initiate | Neutral |
| 2025-07-21 | Keefe, Bruyette & Woods | Maintains | Underperform -> Underperform |
| 2025-07-21 | UBS | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateJan 29, 2026
PeriodQ1 / 2026
EPS Estimate$3.26
Revenue Estimate7.497B
Revenue Q2Q6.17%
EPS Q2Q6.63%
Number of Analysts22
Next Earnings Revisions
Revenue (1 Month)
-0.06%
Revenue (3 Months)
-0.63%
EPS (1 Month)
-0.04%
EPS (3 Months)
-0.26%
Next Earnings Summary
MMC is expected to report earnings on 1/29/2026. The consensus EPS estimate for the next earnings is 3.26 USD and the consensus revenue estimate is 7.50B USD.
The next earnings revenue estimate has been revised downward by 0.63% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 20.72B 4.54% | 22.736B 9.73% | 24.458B 7.57% | 27.209B 11.25% | 28.561B 4.97% | 30.051B 5.22% | 31.623B 5.23% | 32.946B 4.18% | |
| EBITDA YoY % growth | 5.426B 5.32% | 6.296B 16.03% | 6.958B 10.51% | 7.791B 11.97% | 8.352B 7.20% | 8.929B 6.91% | 9.244B 3.53% | 9.58B 3.63% | |
| EBIT YoY % growth | 4.707B 6.86% | 5.583B 18.61% | 6.212B 11.27% | 6.878B 10.72% | 7.362B 7.04% | 7.967B 8.22% | 8.977B 12.68% | 9.481B 5.61% | |
| Operating Margin | 22.72% | 24.56% | 25.40% | 25.28% | 25.78% | 26.51% | 28.39% | 28.78% | |
| EPS YoY % growth | 6.84 10.68% | 7.88 15.20% | 8.80 11.68% | 9.69 10.15% | 10.40 7.25% | 11.34 9.04% | 13.13 15.82% | 14.06 7.08% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 3.26 6.63% | 2.96 8.97% | 1.98 6.90% | 2.19 3.34% | 3.54 8.42% | 3.23 8.96% | 2.18 10.25% | 2.41 10.12% | 3.78 6.98% | 3.44 6.46% | 2.34 7.10% |
| Revenue Q2Q % growth | 7.497B 6.17% | 7.383B 5.86% | 6.72B 5.81% | 6.956B 5.47% | 7.87B 4.98% | 7.757B 5.07% | 7.08B 5.36% | 7.355B 5.74% | 8.301B 5.48% | 8.116B 4.63% | 7.456B 5.31% |
| EBITDA Q2Q % growth | 2.556B 9.14% | 2.36B -0.13% | 1.703B -13.95% | 1.836B 8.32% | 2.697B 5.52% | 2.498B 5.85% | 1.817B 6.69% | 1.94B 5.66% | 2.838B 5.23% | 2.593B 3.80% | 1.87B 2.92% |
| EBIT Q2Q % growth | 2.33B 10.17% | 2.143B 12.49% | 1.497B 15.42% | 1.645B 9.74% | 2.516B 7.98% | 2.326B 8.54% | 1.645B 9.89% | 1.786B 8.57% | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
8.81%
EPS Next 5 Year
9.82%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
6.92%
Revenue Next 5 Year
6.03%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
12.51%
EBIT Next 5 Year
8.85%
MARSH & MCLENNAN COS / MMC Forecast FAQ
What is the price target for MMC stock?
28 analysts have analysed MMC and the average price target is 214.06 USD. This implies a price increase of 17.16% is expected in the next year compared to the current price of 182.7.
When does MARSH & MCLENNAN COS (MMC) report earnings?
MARSH & MCLENNAN COS (MMC) will report earnings on 2026-01-29, before the market open.
Can you provide the consensus estimates for MARSH & MCLENNAN COS next earnings?
The consensus EPS estimate for the next earnings of MARSH & MCLENNAN COS (MMC) is 3.26 USD and the consensus revenue estimate is 7.50B USD.
How do analysts rate MARSH & MCLENNAN COS (MMC)?
The consensus rating for MARSH & MCLENNAN COS (MMC) is 67.8571 / 100 . This indicates that analysts generally have a neutral outlook on the stock.